Pfizer Anokion Celiac Disease Study
Ages
Location
Compensation
Celiac Disease Trials in Columbus
Centricity Research is currently participating in the Pfizer Anokion celiac disease study at our Columbus, Ohio location. Celiac disease is a serious autoimmune disease that occurs in genetically predisposed people where the ingestion of gluten leads to damage in the small intestine. Currently, there is no drug that is available to treat celiac disease. The only available option is following a strict gluten-free diet (GFD). Clinical trials are a necessary part of finding treatment for celiac disease.
Pfizer Anokion Celiac Disease Study
The purpose of this study is to evaluate the safety and tolerability of an investigational drug for alleviating symptoms associated with celiac disease in patients diagnosed with celiac disease. You may be eligible to participate if you:
- Are 18-70 years old
- Have been diagnosed with celiac disease
- Have followed a gluten-free diet for 12+ months prior to study
- Are not diagnosed with a gastrointestinal disease or T1DM
Ready to Volunteer?
Volunteer today to see if you qualify for the Pfizer-Anokion celiac disease clinical research study. Qualified volunteers may be compensated for time and travel.